2 Matching Annotations
  1. Last 7 days
    1. Sixteen patients were screened for variants in one or more of the RCC predisposition genes VHL, FH, FLCN, MET or SDHB (Table 2). No pathogenic variants were found in FH, FLCN, MET or SDHB, but we did find a start codon variant (c.3G>A, p.Met1Ile) and a missense variant (c.631A>C, p.Met211Leu) in VHL in a patient from cohort 2 (Fig 3). Both VHL variants are classified as class 3 variants (VUS) according to the classification guidelines from IARC [26].Open in a separate windowFig 3Pedigree of family 6002.The arrow indicates the proband. The age of RCC-onset and histological subtype the renal tumor is listed below the proband (III:3). A start codon VUS (c.3G>A, p.Met1Ile) and a missense variant (c.631A>C, p. Met211Leu) in VHL and a intron variant (c.1729+8T>C) in BAP1 was identified in a peripheral blood sample from the proband. The proband’s maternal uncle (II:1) was diagnosed with testicular cancer.

      PatientID: III:1

      KindredID: 6002

      Case: M, 28Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: Maternal uncle (II:1) had a history of testicular cancer but no genetic data was available.

      CohortInfo: Patients met at least one of the criteria: RCC < forty years of age or bilateral or multifocal RCC < sixty years of age or family history of RCC or three relatives with RCC, melanoma or mesothelioma (at least one case of RCC) or patients diagnosed with RCC and melanoma. Family history of RCC is defined as two or more first-degree relatives with RCC. Patients with a previously identified pathogenic variant in a renal cancer predisposition gene were not included. Patient inclusion took place from February 2014 to January 2015. This patient was grouped in “Group 1” where only one family member was affected by renal cell carcinoma (n=20).

      CasePresentingHPOs: HP:0006770 (Clear cell renal cell carcinoma)

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: The patient has been through the national screening program for putative VHL, which includes MRI of the cerebrum, spinal medulla and abdomen, neurological examination, auditory tests, ocular examination and blood work for chromogranin A and metanephrines, with normal results.

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Figure 3

      Variant: p.M1I (c.3G>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 135406, https://www.ncbi.nlm.nih.gov/clinvar/variation/135406/

      CAID: N/A

      gnomAD: 0.00007043, https://gnomad.broadinstitute.org/variant/3-10183534-G-A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: M1I (c.3G>A)

      MultipleGeneVariants: Germline, VHL, c.631A>C (p.Met211Leu)

      MultipleGeneVariants: Germline, BAP1, c.1729+8T>C

    1. F28greenFemale28Complete deletion2nd R (1 prior L)No>Yes21.613No

      PatientID: None

      KindredID: 6

      Case: F, 28Y0M, Ethnicity Unknown

      DiseaseAssertion: Clear Cell Renal Cell Carcinoma

      FamilyInfo: N/A

      CohortInfo: The National Cancer Institute has a frozen tumour bank of ccRCC tumours that have been removed from VHL patients. We selected six patients, three males and three females, with at least five tumours from a single surgery from one kidney.

      CasePresentingHPOs: HP:0006770 (clear cell renal cell carcinoma)

      CaseHPOFreeText: The patient presented with ccRCC at age 28.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: Exon 1-3 Loss

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: In the 13 tumours that was sequenced from this patient, 10 had completely lost the other copy of chromosome 3.

      MutationType: exon_loss_variant

      CivicName: Deletion

      MultipleGeneVariants: N/A